Trial intelligence / Profile preview

Antibiotics +/- G-CSF in Pediatric Chemotherapy-Induced Febrile Neutropenia

NCT00003739Phase 3Completed

Sponsor
Children's Oncology Group
Start
Mar 1999
Primary completion
Dec 2002
Modality
Cytokines & Interferons
Countries
7
01

Overview

A Phase 3 trial of filgrastim in febrile neutropenia (FN), sponsored by Children's Oncology Group. Started Mar 1999; status: completed.

02

Drugs

filgrastim
03

Conditions

febrile neutropenia (FN)

Beyond the preview

Go deeper on NCT00003739.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003739.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call